who we are
About Marshall & Stevens
Atlantix Partners
Commitment To People
Our Team
2022 Year In Review
Professional Designations & Regulatory Compliance
Who We Serve
Business Owner
Company Management
Equity & Debt Investor
Transaction Advisor
What We Do
Bankruptcy & Restructuring
business valuation
Financial Reporting
Private Equity Reporting
SPAC Valuation
Financial Valuation
Private Equity Reporting
SPAC Valuation
Tax Valuation Opinions
Dispute & Litigation Support
Energy & Infrastructure
Energy Industry Valuation
Infrastructure Industry
Repowering Energy Projects
Estate and Gift Tax Valuation
ESOP Valuation
Fairness Opinions
Finance & Recapitalization
Financial Reporting Valuation
Private Equity Reporting
Equity Compensation Valuation (IRC 409A/ASC 718)
Impairment Testing (ASC 350 & 360, IAS 36)
Purchase Price Allocation (ASC 805, IFRS 3)
SPAC Valuation
Healthcare Valuation
Intangible Asset Valuation
MS Capital
Machinery & Equipment
Insurance Valuation
Private Equity Reporting
Real Estate Valuation
Private Equity Reporting
Insurance Valuation
Solvency Opinions
SPAC Valuation
tax valuations
Cost Segregation
Equity Compensation Valuation (IRC 409A/ASC 718)
Featured Industries
Academic Institutions
Cannabis
Energy Industry
Repowering Energy Projects
Healthcare Practices and Facilities
Infrastructure
Repowering Energy Projects
SPAC Valuation
News
News
Publications
Join Our Team
Contact Us
Publication
Interim Impairment Testing – Financial Reporting Insight
Mar 28, 2020
Share This:
